Announcements

The Foundation’s Role in Advancing Medical Product Development in the United States
Read More
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
Read More
Call for Nominations for the 2026 Innovations in Regulatory Science & Policy Awards
The Reagan-Udall Foundation for the FDA invites nominations for its annual Innovations in Regulatory Science & Policy Awards.
Read More
More Announcements

Coverage

This Week at FDA: Pregnancy exposure registries, PRV fee rates, and more
The Reagan-Udall Foundation for the FDA and FDA are also co-hosting a hybrid meeting on 16 October to discuss where the patient voice is needed in the rare disease product development timeline, its impact, and opportunities for patients to engage in the…
Read More
Regan-Udall Foundation Report Provides Recommendations Related to Infant Formula Safety
The Reagan-Udall Foundation recently released a report summarizing lessons learned following investigations into 2025 and 2026 infant formula recalls due to the presence of Clostridium botulinum (C. botulinum).
Read More
Abbott Is Selling Sterility as a Feature. In Liquid Formula It Is Already the Rule
This month the Reagan-Udall Foundation published Applying the Science of Infant Formula Safety, a report on a July 13 roundtable convened with, and funded by, ByHeart and the International Dairy Foods Association.
Read More
More Coverage